Ortho Clinical Diagnostics
QuidelOrtho Preliminary Q4 Earnings Beat Estimates
The firm expects its Q4 non-COVID core revenues to increase approximately 18 percent and full-year core revenues to increase approximately 11 percent.
QuidelOrtho, Runda Medical to Form Immunodiagnostic Joint Venture in China
The joint venture will develop and manufacture assays in China for QuidelOrtho's Vitros immunodiagnostic platform.
The firm also said it will shift its near-term regulatory and commercial strategy for its Savanna molecular diagnostic instrument.
360Dx Top 30 Rises 2 Percent After Months of Decline
Of the 30 companies in the index, 22 saw their stock prices rise, while eight firms saw their share prices decrease.
QuidelOrtho Reports Preliminary Q3 Revenues
The firm forecast preliminary revenues in the range of $782 million to $785 million for the first full quarter since the merger of Quidel and Ortho Clinical Diagnostics.
Aug 18, 2022
QuidelOrtho Board Authorizes $300M Share Repurchase
Aug 5, 2022
QuidelOrtho Q2 Revenues Rise 34 Percent
Jan 6, 2022